NTLA logo

Combined Holdings of NTLA in All ARK ETFs

Intellia Therapeutics

Intellia Therapeutics is a biotechnology company focused on the development of therapies using CRISPR/Cas9 gene-editing technology to potentially treat genetic diseases. The company generates revenue through partnerships, collaborations, and the development of proprietary treatments aimed at commercializing innovative gene-editing solutions.

Trades of NTLA in All Ark ETFs

The ten most recent trades of Intellia Therapeutics in all the Ark ETFs ETF.View all trades

Date
Direction
Market Value
% of Position
% of ETF
Jan 21, 2025Buy$225,7720.81%0.02%
Jan 21, 2025Buy$676,5780.81%0.01%
Jan 10, 2025Buy$1,332,8531.46%0.02%
Jan 10, 2025Buy$443,2521.42%0.04%
Jan 08, 2025Buy$898,5210.88%0.01%
Jan 08, 2025Buy$306,6710.88%0.03%
Dec 20, 2024Buy$365,4231.05%0.04%
Dec 20, 2024Buy$2,292,4862.28%0.04%
Dec 18, 2024Buy$307,7510.86%0.03%
Dec 18, 2024Buy$921,2830.90%0.01%